Circulating DNA biomarkers: a primer for metastatic colorectal cancer?

Luis Alberto Diaz, None, The promise of liquid biopsy in colorectal cancer. Clinical advances in hematology & oncology. ,vol. 12, pp. 688- 689 ,(2014)

Josep Tabernero, Heinz-Josef Lenz, Salvatore Siena, Alberto Sobrero, Alfredo Falcone, Marc Ychou, Yves Humblet, Olivier Bouché, Laurent Mineur, Carlo Barone, Antoine Adenis, Takayuki Yoshino, Richard M Goldberg, Daniel J Sargent, Andrea Wagner, Dirk Laurent, Michael Teufel, Michael Jeffers, Axel Grothey, Eric Van Cutsem, None, Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial The Lancet Oncology. ,vol. 16, pp. 937- 948 ,(2015) , 10.1016/S1470-2045(15)00138-2

Alexandre Diehl, Athanassios Z. Panagiotopoulos, Phase diagrams in the lattice restricted primitive model: From order-disorder to gas-liquid phase transition Physical Review E. ,vol. 71, pp. 046118- 046118 ,(2005) , 10.1103/PHYSREVE.71.046118

Yvonne Yeung, Niall C Tebbutt, Bevacizumab in colorectal cancer: current and future directions Expert Review of Anticancer Therapy. ,vol. 12, pp. 1263- 1273 ,(2012) , 10.1586/ERA.12.104

Ana Custodio, Jorge Barriuso, Javier de Castro, Virginia Martínez-Marín, Víctor Moreno, Nuria Rodríguez-Salas, Jaime Feliu, Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives. Cancer Treatment Reviews. ,vol. 39, pp. 908- 924 ,(2013) , 10.1016/J.CTRV.2013.02.004

Jean-Yves Douillard, Kelly S Oliner, Salvatore Siena, Josep Tabernero, Ronald Burkes, Mario Barugel, Yves Humblet, Gyorgy Bodoky, David Cunningham, Jacek Jassem, Fernando Rivera, Ilona Kocákova, Paul Ruff, Maria Błasińska-Morawiec, Martin Šmakal, Jean Luc Canon, Mark Rother, Richard Williams, Alan Rong, Jeffrey Wiezorek, Roger Sidhu, Scott D Patterson, None, Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer The New England Journal of Medicine. ,vol. 369, pp. 1023- 1034 ,(2013) , 10.1056/NEJMOA1305275

Alain R Thierry, Florent Mouliere, Safia El Messaoudi, Caroline Mollevi, Evelyne Lopez-Crapez, Fanny Rolet, Brigitte Gillet, Celine Gongora, Pierre Dechelotte, Bruno Robert, Maguy Del Rio, Pierre-Jean Lamy, Frederic Bibeau, Michelle Nouaille, Virginie Loriot, Anne-Sophie Jarrousse, Franck Molina, Muriel Mathonnet, Denis Pezet, Marc Ychou, Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA Nature Medicine. ,vol. 20, pp. 430- 435 ,(2014) , 10.1038/NM.3511

Axel Grothey, Eric Van Cutsem, Alberto Sobrero, Salvatore Siena, Alfredo Falcone, Marc Ychou, Yves Humblet, Olivier Bouché, Laurent Mineur, Carlo Barone, Antoine Adenis, Josep Tabernero, Takayuki Yoshino, Heinz-Josef Lenz, Richard M Goldberg, Daniel J Sargent, Frank Cihon, Lisa Cupit, Andrea Wagner, Dirk Laurent, None, Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial The Lancet. ,vol. 381, pp. 303- 312 ,(2013) , 10.1016/S0140-6736(12)61900-X

Marco Gerlinger, Andrew J Rowan, Stuart Horswell, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart, Patrick Tarpey, Ignacio Varela, Benjamin Phillimore, Sharmin Begum, Neil Q McDonald, Adam Butler, David Jones, Keiran Raine, Calli Latimer, Claudio R Santos, Mahrokh Nohadani, Aron C Eklund, Bradley Spencer-Dene, Graham Clark, Lisa Pickering, Gordon Stamp, Martin Gore, Zoltan Szallasi, Julian Downward, P Andrew Futreal, Charles Swanton, None, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England Journal of Medicine. ,vol. 366, pp. 883- 892 ,(2012) , 10.1056/NEJMOA1113205